Marimed (MRMD) Notes Payables (2011 - 2026)

Marimed (MRMD) has 16 years of Notes Payables data on file, last reported at $3.3 million in Q1 2026.

• On a quarterly basis, Notes Payables fell 31.15% year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $3.3 million, a 31.15% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, down 50.2% from the prior year.
• Notes Payables for Q1 2026 stood at $3.3 million, up from $2.6 million in the prior quarter.
• Over the last five years, Notes Payables for MRMD reached as high as $5.1 million in Q4 2024 and fell as low as $10000.0 in Q1 2022.
• Historically, Notes Payables has averaged $2.4 million across 5 years, with a median of $2.6 million in 2025.
• Across the five-year window, Notes Payables plunged 80.84% in 2023 and jumped 14237.04% in 2024, its largest moves.
• Year by year, Notes Payables stood at $3.8 million in 2022, then plunged by 80.84% to $723000.0 in 2023, then surged by 608.99% to $5.1 million in 2024, then slumped by 50.2% to $2.6 million in 2025, then rose by 29.06% to $3.3 million in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $3.3 million in Q1 2026, $2.6 million in Q4 2025, and $2.3 million in Q3 2025.